Search

everythinglearnresearchcommunity

for

Search:↓

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Pulsed electric field treatment may help the immune system fight liver tumors.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

Early diagnosis and treatment of myositis in SLE patients lead to positive outcomes.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Early diagnosis and treatment of myositis in SLE patients lead to better outcomes.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Apremilast may help treat hair loss in alopecia areata.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Methotrexate plus prednisolone had the fewest serious side effects.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

The patient had paraneoplastic pemphigus without mucosal involvement.